{{Rsnum
|rsid=10888935
|Chromosome=1
|position=55595278
|Orientation=plus
|GMAF=0.4844
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 37.2 | 48.7 | 14.2
| HCB | 29.9 | 48.2 | 21.9
| JPT | 38.9 | 46.9 | 14.2
| YRI | 4.1 | 27.9 | 68.0
| ASW | 14.0 | 40.4 | 45.6
| CHB | 29.9 | 48.2 | 21.9
| CHD | 32.1 | 45.0 | 22.9
| GIH | 37.6 | 44.6 | 17.8
| LWK | 7.3 | 28.2 | 64.5
| MEX | 51.7 | 44.8 | 3.4
| MKK | 10.3 | 34.6 | 55.1
| TSI | 28.4 | 52.0 | 19.6
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22228203
|Trait=None
|Title=A genome-wide association study of inflammatory biomarker changes in response to fenofibrate treatment in the Genetics of Lipid Lowering Drug and Diet Network.
|RiskAllele=
|Pval=7E-7
|OR=None
|ORtxt=None
|OA=1
}}

{{on chip | Affy GenomeWide 6}}